MedPath

Comparing the effects of providing clinicians and patients with the results of an objective measure of activity and attention (QbTest) versus usual care on diagnostic and treatment decision making in children and young people with ADHD

Not Applicable
Completed
Conditions
Specialty: Mental Health, Primary sub-specialty: Learning disorders
Mental and Behavioural Disorders
Attention deficit hyperactivity disorder (ADHD)
Registration Number
ISRCTN11727351
Lead Sponsor
niversity of Nottingham
Brief Summary

2017 Results article in https://www.ncbi.nlm.nih.gov/pubmed/28183284 results 2017 Other publications in https://pubmed.ncbi.nlm.nih.gov/28183284/ (added 18/08/2023) 2019 Other publications in https://pubmed.ncbi.nlm.nih.gov/31216327/ (added 18/08/2023) 2014 Protocol article in https://pubmed.ncbi.nlm.nih.gov/25448628/ (added 18/08/2023) 2018 Results article in https://pubmed.ncbi.nlm.nih.gov/29700813/ (added 18/08/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
178
Inclusion Criteria

1. Age 6-17 years (maximum 17 years at time of consent, may turn 18 during the study)
2. Referred for ADHD assessment
3. Capable of providing written informed consent (over 16)
4. Parental consent (under 16)

Exclusion Criteria

1. Non-fluent in English
2. Suspected moderate or severe learning disability
3. Previous or current diagnosis of ADHD

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
umber of clinic sessions until a confirmed correct diagnosis is achieved is measured using an appointment pro-forma from baseline to 6 months.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath